Latest Articles

All Latest Articles

152376 Articles

Lee Jackson | Aug 9, 2023 at 8:58 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Amazon, Beyond Meat, DraftKings, Home Depot, Lowe’s, Palantir, Walmart and More

Wednesday's top analyst upgrades and downgrades included Amazon.com, Beyond Meat, Compass, DraftKings, Genius Sports, Home Depot, International Flavors & Fragrances,…

John Harrington | Aug 9, 2023 at 8:00 AM EDT

Best Movies to Stream on Amazon Prime Right Now, According to Data

Whether they are considered classic or contemporary or anything in between, Amazon Prime has dipped into its film library in…

Paul Ausick | Aug 9, 2023 at 7:35 AM EDT

Morning Blast: Not-So Super Superconductor; Disney Takes the Odds

It appears that we will have to wait for superconductivity. In the meantime, we will be able to bet on…

Douglas A. McIntyre | Aug 9, 2023 at 7:30 AM EDT

Where Will WeWork Renters Go?

Office rental company WeWork may run out of money and go out of business.

Lee Jackson | Aug 9, 2023 at 7:10 AM EDT

Moody’s Slashes Ratings on Top US Banks: 5 ‘Strong Buy’ Dividend Giants Are the Only Safe Plays Now

Moody’s has downgraded a number of smaller and regional banks, but these five mega-cap financial giants will likely weather any…

247patrick | Aug 9, 2023 at 6:55 AM EDT

Goldman Sachs Maintains Elanco Animal Health Sell Recommendation

Goldman Sachs has maintained coverage of Elanco Animal Health with a Sell recommendation.

247patrick | Aug 9, 2023 at 6:55 AM EDT

If There’s a Recession in the Offing, Magna Doesn’t Appear to Be Feeling the Heat … Yet!

Magna International reports healthy revenue and earnings growth in the second quarter, but shares lost ground because of labor concerns.

247patrick | Aug 9, 2023 at 6:55 AM EDT

Goldman Sachs Downgrades Sage Therapeutics

Goldman Sachs has downgraded its outlook for Sage Therapeutics to Neutral.

247patrick | Aug 9, 2023 at 6:55 AM EDT

Don’t Overlook These Affordable Stocks as Earnings Approach

Several top-rated stocks are starting to look cheap ahead of their quarterly reports.

247patrick | Aug 9, 2023 at 6:55 AM EDT

3 Intriguing Stocks to Buy After Earnings

There appears to be opportunity in several top-rated stocks after reporting their quarterly results.

247patrick | Aug 9, 2023 at 6:55 AM EDT

3 High-Yield Bond Funds to Buy for Great Returns

These three top-ranked high-yield bond mutual funds are expected to outperform their peers.

Trey Thoelcke | Aug 9, 2023 at 4:45 AM EDT

ESG risks start filtering into merger deals as disaster costs soar

Plus, new fusion breakthrough leaves investors searching for nuclear plays.

247patrick | Aug 8, 2023 at 11:34 PM EDT

Wedbush Downgrades Chinook Therapeutics

Wedbush has downgraded its outlook for Chinook Therapeutics to Neutral.

247patrick | Aug 8, 2023 at 11:34 PM EDT

Goldman Sachs Upgrades Paymentus

Goldman Sachs has upgraded its outlook for Paymentus to Neutral.

247patrick | Aug 8, 2023 at 11:34 PM EDT

Goldman Sachs Maintains Compass Buy Recommendation

Goldman Sachs has maintained coverage of Compass with a Buy recommendation.

1 … 2,227 2,228 2,229 2,230 2,231 … 10,159

Latest Articles

All Latest Articles

Wednesday’s Top Analyst Upgrades and Downgrades: Amazon, Beyond Meat, DraftKings, Home Depot, Lowe’s, Palantir, Walmart and More

Best Movies to Stream on Amazon Prime Right Now, According to Data

Morning Blast: Not-So Super Superconductor; Disney Takes the Odds

Where Will WeWork Renters Go?

Moody’s Slashes Ratings on Top US Banks: 5 ‘Strong Buy’ Dividend Giants Are the Only Safe Plays Now

Goldman Sachs Maintains Elanco Animal Health Sell Recommendation

If There’s a Recession in the Offing, Magna Doesn’t Appear to Be Feeling the Heat … Yet!

Goldman Sachs Downgrades Sage Therapeutics

Don’t Overlook These Affordable Stocks as Earnings Approach

3 Intriguing Stocks to Buy After Earnings

3 High-Yield Bond Funds to Buy for Great Returns

ESG risks start filtering into merger deals as disaster costs soar

Wedbush Downgrades Chinook Therapeutics

Goldman Sachs Upgrades Paymentus

Goldman Sachs Maintains Compass Buy Recommendation

63-Year-Old With $2.2M Discovers Pension Buyout Decision Could Cost His Widow $310,000

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

For Most Retirees, Only One Arizona City Actually Makes Sense. Here’s Which.

63-Year-Old With $2.2M Discovers Pension Buyout Decision Could Cost His Widow $310,000

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

Trump Just Made An Obscure Pentagon Office Bigger Than The Marine Corps. Here Are 5 Stocks For This $1.5 Trillion Defense Opportunity

63-Year-Old With $2.2M Discovers Pension Buyout Decision Could Cost His Widow $310,000

Latest Articles

All Latest Articles

Wednesday’s Top Analyst Upgrades and Downgrades: Amazon, Beyond Meat, DraftKings, Home Depot, Lowe’s, Palantir, Walmart and More

Best Movies to Stream on Amazon Prime Right Now, According to Data

Morning Blast: Not-So Super Superconductor; Disney Takes the Odds

Where Will WeWork Renters Go?

Moody’s Slashes Ratings on Top US Banks: 5 ‘Strong Buy’ Dividend Giants Are the Only Safe Plays Now

Goldman Sachs Maintains Elanco Animal Health Sell Recommendation

If There’s a Recession in the Offing, Magna Doesn’t Appear to Be Feeling the Heat … Yet!

Goldman Sachs Downgrades Sage Therapeutics

Don’t Overlook These Affordable Stocks as Earnings Approach

3 Intriguing Stocks to Buy After Earnings

3 High-Yield Bond Funds to Buy for Great Returns

ESG risks start filtering into merger deals as disaster costs soar

Wedbush Downgrades Chinook Therapeutics

Goldman Sachs Upgrades Paymentus

Goldman Sachs Maintains Compass Buy Recommendation

63-Year-Old With $2.2M Discovers Pension Buyout Decision Could Cost His Widow $310,000

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

For Most Retirees, Only One Arizona City Actually Makes Sense. Here’s Which.

Featured Reads

63-Year-Old With $2.2M Discovers Pension Buyout Decision Could Cost His Widow $310,000

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later